X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (322) 322
Book Review (25) 25
Conference Proceeding (23) 23
Publication (22) 22
Magazine Article (5) 5
Book Chapter (3) 3
Newspaper Article (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (173) 173
humans (147) 147
oncology (111) 111
male (77) 77
middle aged (76) 76
female (73) 73
aged (58) 58
adult (57) 57
melanoma (56) 56
animals (55) 55
cancer (53) 53
immunotherapy (53) 53
immunology (49) 49
mice (46) 46
t cells (37) 37
metastasis (35) 35
melanoma - drug therapy (33) 33
metastatic melanoma (32) 32
lymphocytes (31) 31
care and treatment (30) 30
ipilimumab (30) 30
medicine, research & experimental (30) 30
antineoplastic agents - therapeutic use (29) 29
treatment outcome (29) 29
research (28) 28
survival (27) 27
t-lymphocytes - immunology (27) 27
carcinoma, renal cell - drug therapy (26) 26
kidney neoplasms - drug therapy (26) 26
clinical trials (24) 24
in-vivo (24) 24
abridged index medicus (23) 23
cd8-positive t-lymphocytes - immunology (23) 23
drug therapy (23) 23
interferon-alpha (23) 23
tumors (23) 23
indoles - therapeutic use (22) 22
aged, 80 and over (21) 21
melanoma - pathology (21) 21
disease-free survival (20) 20
mice, inbred c57bl (20) 20
analysis (19) 19
cell biology (19) 19
expression (19) 19
melanoma - immunology (19) 19
metastases (19) 19
skin neoplasms - drug therapy (18) 18
therapy (18) 18
carcinoma (17) 17
kidney neoplasms - pathology (17) 17
mutation (17) 17
antigens (16) 16
biochemistry & molecular biology (16) 16
sunitinib (16) 16
antigen (15) 15
dosage and administration (15) 15
melanoma - genetics (15) 15
melanoma - therapy (15) 15
patients (15) 15
prognosis (15) 15
pyrroles - therapeutic use (15) 15
cancer regression (14) 14
neoplasm staging (14) 14
skin neoplasms - pathology (14) 14
survival analysis (14) 14
tumor-infiltrating lymphocytes (14) 14
antibodies, monoclonal - therapeutic use (13) 13
antigens, neoplasm - immunology (13) 13
lymphocytes t (13) 13
medicine & public health (13) 13
toxicity (13) 13
usage (13) 13
antineoplastic agents - adverse effects (12) 12
cancer research (12) 12
chemotherapy (12) 12
health aspects (12) 12
mice, transgenic (12) 12
neoplasm metastasis (12) 12
neoplasms - immunology (12) 12
neoplasms - therapy (12) 12
nephrectomy (12) 12
proto-oncogene proteins b-raf - genetics (12) 12
retrospective studies (12) 12
survival rate (12) 12
vaccines, dna - immunology (12) 12
vemurafenib (12) 12
antineoplastic combined chemotherapy protocols - therapeutic use (11) 11
cell line, tumor (11) 11
flow cytometry (11) 11
in vitro techniques (11) 11
indoles - adverse effects (11) 11
kaplan-meier estimate (11) 11
lymphocytes, tumor-infiltrating - immunology (11) 11
medicine, general & internal (11) 11
melanoma - mortality (11) 11
receptors, antigen, t-cell - genetics (11) 11
safety (11) 11
targeted therapy (11) 11
trial (11) 11
urology & nephrology (11) 11
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 07/2015, Volume 373, Issue 1, pp. 23 - 34
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 11/2014, Volume 371, Issue 20, pp. 1877 - 1888
Journal Article
Cell, ISSN 0092-8674, 09/2017, Volume 170, Issue 6, pp. 1055 - 1056
In a small phase Ib study in this issue of , Ribas et al. report that the combination of intralesional injection of a modified human herpes simplex virus and... 
MELANOMA | PD-1 BLOCKADE | BIOCHEMISTRY & MOLECULAR BIOLOGY | CELL BIOLOGY | Injections, Intralesional | Humans | Immunotherapy | Melanoma | Drug therapy | T cells | Tumors | Index Medicus
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 10/2017, Volume 377, Issue 14, pp. 1345 - 1356
Journal Article
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 06/2011, Volume 364, Issue 26, pp. 2507 - 2516
Journal Article
Annals of Oncology, ISSN 0923-7534, 11/2015, Volume 26, Issue suppl 7, pp. vii7.1 - vii7
Journal Article
European Journal of Immunology, ISSN 0014-2980, 06/2016, Volume 46, Issue 6, pp. 1351 - 1360
Tumor infiltrating lymphocyte (TIL) therapy has shown objective clinical response rates of 50% in stage IV melanoma patients in a number of clinical trials.... 
Antigens ⋅ CD8 | T cells ⋅ Enrichment ⋅ Melanoma ⋅ TIL therapy | Enrichment | Antigens | TIL therapy | T cells | CD8 | Melanoma | PHASE-II | IMMUNOLOGY | IDENTIFICATION | TUMOR-INFILTRATING LYMPHOCYTES | MHC CLASS-I | ADOPTIVE CELL THERAPY | METASTATIC MELANOMA | LUNG-CANCER | REACTIVE T-CELLS | CD8(+) T cells | PREDICTIONS | VEMURAFENIB | T-Lymphocyte Subsets - immunology | Immunotherapy - methods | Humans | Protein Multimerization - immunology | HLA Antigens - genetics | Lymphocyte Activation - genetics | Lymphocyte Activation - immunology | Melanoma - genetics | T-Cell Antigen Receptor Specificity - immunology | Lymphocytes, Tumor-Infiltrating - metabolism | Cell Culture Techniques | Epitopes, T-Lymphocyte - immunology | Melanoma - metabolism | Antigens, Neoplasm - immunology | HLA Antigens - immunology | Immunophenotyping | HLA Antigens - chemistry | HLA Antigens - metabolism | Melanoma - immunology | T-Lymphocyte Subsets - metabolism | Biomarkers | Cell Line, Tumor | Protein Binding | Melanoma - therapy | Epitopes, T-Lymphocyte - metabolism | Precision Medicine - methods | Cytotoxicity, Immunologic | Lymphocytes, Tumor-Infiltrating - immunology | Antimitotic agents | Care and treatment | Immunotherapy | Drug therapy | Antineoplastic agents | Cancer | Antigenic determinants | Response rates | Index Medicus
Journal Article